One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Vertical light inspection machine can inspect small round bottles such as vials, ampoule bottles, oral liquid bottles and jars, which is suitable for pharmaceutical, daily chemicals, food and other industries to inspect the appearance and content of products. It has the characteristics of stable operation and high efficiency, and can be connected with production line or work alone.
Functional Features
Wide compatibility, various specifications of round bottles can be inspected by replacing the supporting mold.
The molds are quick disassembly designed, which results in the quick and easy product changeover.
Comprehensive inspection includes a variety of appearance inspection (dents, bumps, etc.) and content inspection (sediment, suspended particles, etc.).
The inspection is reliable and adopts a camera following moving products method to further improve the inspection accuracy.
With accurate rejection, the unqualified products can be sent to different rejection channels according to the inspection results.
Strong security, the whole machine is equipped with safety cover, safety door and safety switch, with CE certification standards.
PLC can be equipped with network interface to facilitate the docking of production system software (such as MES, ERP, etc.).
Based on the underlying algorithm of USA Cognex to ensure the stability, and combined with years of experience in the application and development in the pharmaceutical industry, the inspection program can be deeply customized.
When inspecting the appearance of products, AI intelligent algorithm is used to achieve higher inspection rate and lower misjudgment rate.
Audited Supplier
Pharma Sources Insight January 2025
